Looking back at Trump’s tenure, and the potential implications of the US elections for pharma and the Affordable Health Act.

Graeme Dennis questions why the industry refuses to make use of the significant amount of data it generates.

How is African pharma coping with the COVID-19 pandemic?

What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.